These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11870657)

  • 1. Permeation of protein from porous poly(epsilon-caprolactone) films.
    Lu CH; Lin WJ
    J Biomed Mater Res; 2002; 63(2):220-5. PubMed ID: 11870657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes.
    Li Y; Jiang H; Zhu K
    J Mater Sci Mater Med; 2008 Feb; 19(2):827-32. PubMed ID: 17665113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinoptilolite/PCL-PEG-PCL composite scaffolds for bone tissue engineering applications.
    Pazarçeviren E; Erdemli Ö; Keskin D; Tezcaner A
    J Biomater Appl; 2017 Mar; 31(8):1148-1168. PubMed ID: 27881642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of magnetic poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) microspheres.
    Gou ML; Qian ZY; Wang H; Tang YB; Huang MJ; Kan B; Wen YJ; Dai M; Li XY; Gong CY; Tu MJ
    J Mater Sci Mater Med; 2008 Mar; 19(3):1033-41. PubMed ID: 17701292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical and biodegradability of porous PCL/PEG copolymer-reinforced cellulose nanofibers for soft tissue engineering applications.
    Ghalia MA; Alhanish A
    Med Eng Phys; 2023 Oct; 120():104055. PubMed ID: 37838404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zero-order release of lysozyme from poly(ethylene glycol)/poly(butylene terephthalate) matrices.
    Bezemer JM; Radersma R; Grijpma DW; Dijkstra PJ; Feijen J; van Blitterswijk CA
    J Control Release; 2000 Feb; 64(1-3):179-92. PubMed ID: 10640656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermoresponsive biodegradable PEG-PCL-PEG based injectable hydrogel for pulsatile insulin delivery.
    Payyappilly S; Dhara S; Chattopadhyay S
    J Biomed Mater Res A; 2014 May; 102(5):1500-9. PubMed ID: 23681592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of epsilon-caproyl/D,L-lactyl unit composition on the hydrolytic degradation of poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone).
    Cho H; An J
    Biomaterials; 2006 Feb; 27(4):544-52. PubMed ID: 16099497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
    Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
    Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
    Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
    J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone) as parenteral drug-delivery systems.
    Cho H; Chung D; Jeongho A
    Biomaterials; 2004 Aug; 25(17):3733-42. PubMed ID: 15020149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymer for paclitaxel.
    Wang C; Liang J; Deng X; Long C; Xie C; Chen X; Zhang L; Guo Q; Wang Y; Wang Y; Luo F; Qian Z
    J Nanosci Nanotechnol; 2013 Jan; 13(1):68-76. PubMed ID: 23646699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.
    Stanković M; Tomar J; Hiemstra C; Steendam R; Frijlink HW; Hinrichs WL
    Eur J Pharm Biopharm; 2014 Jul; 87(2):329-37. PubMed ID: 24602675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cellular proliferation on dense and porous PCL scaffolds.
    Saşmazel HT; Gümüşderelioğlu M; Gürpinar A; Onur MA
    Biomed Mater Eng; 2008; 18(3):119-28. PubMed ID: 18725692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymers with nanophase separation.
    Hsu SH; Tang CM; Lin CC
    Biomaterials; 2004 Nov; 25(25):5593-601. PubMed ID: 15159075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive poly(ε-caprolactone) microspheres with tunable open pores as microcarriers for tissue regeneration.
    Zhou A; Ye Z; Zhou Y; Tan WS
    J Biomater Appl; 2019 Apr; 33(9):1242-1251. PubMed ID: 30782056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
    Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
    Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.